Patients in the United States have sued the makers of Ozempic and Mounjaro over vision loss. The development comes as GLP-1 medicines become increasingly available in Nigeria. A recent PREMIUM TIMES investigation found that the injections were being sold online without prescriptions or evidence of medical supervision. The lawsuits raise concerns about the safety and regulation of these drugs.
Related Articles
Don't miss out on breaking stories and in-depth articles.